Researchers at the University of California, San Diego School of Medicine have found that the risk of patient harm increased two-fold in 2006, which was the peak year that teaching hospitals nationwide embraced minimally invasive robotic surgery for prostate cancer. Results of the study are published in today's online issue of JAMA Surgery.